The 8;21 translocation produces a fusion between the ETO gene and that encoding the myeloid transcription factor AML1. The AML1-ETO fusion substitutes the majority of the ETO protein for the coregulator recruitment domains of AML1. Biochemical analyses of ETO have led to the identification of numerous interacting proteins including many corepressors. Importantly, the proteins interacting with ETO are different from those of wild-type AML1, suggesting that altered coregulator recruitment underlies the oncogenic properties of AML1-ETO. The list of corepressors capable of binding ETO includes histone deacetylases (HDACs) and components of distinct HDAC core complexes. These investigations have provided mechanistic insight into corepressor recruitment by ETO and clues to the leukemogenic activity of AML1-ETO.
Introduction ETO (also called MTG8 or CBFA2T1) is best known as the fusion partner of AML1 in leukemias carrying the 8;21 translocation (Miyoshi et al., 1993; Downing, 1999) . Indeed, the protein's name is an acronym for the translocation (Eight Twenty-One) (Miyoshi et al., 1993) . While AML1 has been studied extensively and is a well-characterized determinant of hematopoietic development, ETO is understood less well (Downing, 1999) . ETO interacting proteins have provided some insight into the protein's function and lead to the widely accepted conclusion that ETO acts as a transcriptional corepressor (Gelmetti et al., 1998; Lutterbach et al., 1998b; Wang et al., 1998) . ETO interacts with the corepressors N-CoR and SMRT, Sin3, and numerous HDACs (Gelmetti et al., 1998; Lutterbach et al., 1998b; Wang et al., 1998; Hildebrand et al., 2001) . These findings are consistent with ETO facilitating repression by DNA-binding factors such as PLZF or GFI-1 (Melnick et al., 2000; Davis et al., 2003) . However, the mechanistic details of repression are complicated by ETO's interactions with factors that often represent distinct core corepressor complexes (Gelmetti et al., 1998; Lutterbach et al., 1998b; Wang et al., 1998; Hildebrand et al., 2001) . The functions of these core complexes and their interplay in the regulation of gene expression are a subject of intense focus by transcriptional biologists and are likely to be the keys to understanding the transcriptional activity of ETO.
ETO family
Following the identification of ETO as a fusion partner of AML1, a family of genes conserved from Drosophila through humans was quickly defined. The human family consists of three members including ETO (or MTG8, myeloid translocation gene 8), MTG16, and MTG-R1. The mouse has a similar family. ETO-2 is the mouse homologue of MTG16 (Davis et al., 1999) . Expression patterns of the ETO family members are ubiquitous (Wolford and Prochazka, 1998; Morohoshi et al., 2000) . Therefore, even though ETO has historically been studied for its role in leukemia, the gene family has roles outside of the hematopoietic system. Indeed, expression of ETO is the highest in neurons, reminiscent of its Drosophila homologue, Nervy (Wolford and Prochazka, 1998) . Each of the family members has transcriptional splice variants, but none of these disrupt the conserved domain structures of the proteins discussed below (Miyoshi et al., 1993; Gamou et al., 1998; Wolford and Prochazka, 1998; Morohoshi et al., 2000) .
ETO sequence and homology
ETO has four domains named Nervy Homology Regions 1-4 (NHR1-4) because of their similarity to the Drosophila Nervy protein (Figure 1 ; Feinstein et al., 1995) . The conservation of ETO NHRs with the Drosophila protein range from 50 to 70% (Feinstein et al., 1995; Davis et al., 2003) . NHR1 has homology to several TATA-binding protein-associated factors, including human TAF105 and TAF130 as well as Drosophila TAF110 (Erickson et al., 1994; Kozu et al., 1997) . The conservation of NHR1 with these TAFs provided an early hint that ETO functioned as a transcription factor (Feinstein et al., 1995) . This domain does not appear to be important for repression by ETO in vitro, but may have a role in subnuclear localization (Odaka et al., 2000) . NHR2 is termed the hydrophobic heptad repeat region because of the composition of the alpha helical sequences of the domain (Lutterbach et al., 1998a) . As will be discussed later, this small region participates in multiple interesting interactions that are important for some of the best-studied properties of ETO. NHR3 does not share informative characteristics with previously described domains, but may participate in interactions in conjunction with NHR4 (Hildebrand et al., 2001) . NHR4 has two non-DNA-binding zincfingers that are shared by proteins BS69, BOP, and DEAF1 (Gross and McGinnis, 1996; Lutterbach et al., 1998a; Ansieau and Leutz, 2002; Gottlieb et al., 2002) . These proteins have in common the ability to recruit transcriptional corepressors. Sequences outside of the four NHRs were overlooked for many years because of their lack of similarity to Nervy. Nevertheless, several non-conserved areas were recently shown to contribute to associations between ETO and other corepressors (Amann et al., 2001) . The NHRs, therefore, highlighted regions important for transcriptional properties of ETO, but possibly not all of the activities of the protein.
ETO interactions
The biochemical interactions between ETO and other factors have provided insight to ETO's mechanism of action. Since AML1-ETO opposes the activity of AML1, the area of greatest focus has been on the associations between ETO and transcriptional corepressors. Interestingly, multiple domains throughout ETO contribute corepressor contacts. Additionally, corepressors from distinct core complexes, that ordinarily do not copurify, are capable of binding to ETO. These findings suggest multiple potential mechanisms by which ETO can repress gene expression and AML1-ETO can interfere with AML1.
This link between ETO and transcriptional repression naturally promoted searches for interactions with the histone deacetylases (HDACs) (Gelmetti et al., 1998; Lutterbach et al., 1998b; Wang et al., 1998) . HDACs are the enzymatic components of multiprotein complexes such as the N-CoR, SMRT, and Sin3 complexes (Zhang et al., 1997 (Zhang et al., , 1999 Xue et al., 1998; Guenther et al., 2000; Li et al., 2000; Wen et al., 2000; You et al., 2001; Humphrey et al., 2001; Yoon et al., 2003) . Deacetylation of histone tails influences the interactions between histones and key transcriptional regulatory proteins (Iizuka and Smith, 2003) . HDACs can, thereby, regulate gene expression by contributing to the establishment of a 'histone code' (Iizuka and Smith, 2003) . Additionally, HDACs can act upon other transcription factors to control DNA binding, nuclear localization, or transcriptional activity (Hung et al., 1999 (Hung et al., , 2001 Brooks and Gu, 2003) . Therefore, numerous potential mechanisms of action are available to the transcription factors that recruit HDACs.
ETO recruits HDACs through direct and indirect mechanisms. Many interactions with ETO are through direct contacts between domains of ETO and HDACs themselves. Other interactions are between ETO and components of complexes that contain HDACs. Numerous potentially important domains have been described, and many of these make cooperative or redundant contributions with other regions. HDAC recruitment, therefore, appears to be of fundamental importance to transcriptional repression by ETO.
Direct interactions with HDACs
ETO family members can interact with at least five HDACs (Amann et al., 2001) . HDACs 1 and 2 were the first deacetylases shown to interact with ETO (Gelmetti et al., 1998; Lutterbach et al., 1998b; Wang et al., 1998) . A recent investigation indicated that ETO also interacts with HDAC3 (Amann et al., 2001) . Interestingly, ETO-2 interacts with HDACs 1, 2, 3, 6, and 8 (Amann et al., 2001) . The association between ETO and transcriptional repression strongly suggests that at least some of these HDAC interactions are functionally significant. Consistent with this, HDAC inhibitors can block the effects of AML1-ETO on the cell cycle (Amann et al., 2001) .
Interactions between ETO and specific HDAC family members have most often been observed in vitro or in cells in which ETO and/or the HDAC has been overexpressed. It therefore remains unclear as to which HDACs are critical to the biological functions of ETO. Purified HDACs exist in multiprotein complexes (Guenther et al., 2000; Li et al., 2000; Zhang et al., 2002; Yoon et al., 2003) that might predict biochemical interaction profiles for ETO. Both HDACs 1 and 2 copurify with the Sin3 and NuRD complexes, while HDAC3 copurifies with the N-CoR and SMRT complexes. HDACs 6 and 8 have not yet been assigned to complexes, and they are not members of any of the aforementioned complexes. Thus, for example, the functional dependence of ETO on HDAC3 would likely require a direct or indirect association with N-CoR or SMRT, because these proteins are essential for HDAC3's histone deacetylase activity (Guenther et al., Figure 1 Schematic depiction of ETO and its protein interaction domains. A map of ETO is shown with NHR1-4 indicated as shaded regions. Interacting corepressors are listed with the corresponding ETO-interaction domains underlined (Amann et al., 2001; Gelmetti et al., 1998; Hildebrand et al., 2001; Lutterbach et al., 1998a, b; Zhang et al., 2001) 2000; Li et al., 2000; Zhang et al., 2002; Yoon et al., 2003) . Similarly, interactions with HDACs 1 and 2 would predict interactions with members of the Sin3 or NuRD complexes (Zhang et al., 1997 (Zhang et al., , 1999 . Domain mapping of ETO has localized critical HDAC contact sites to NHR2 and NHR4, although domains throughout ETO also contribute unique contacts for each HDAC (Gelmetti et al., 1998; Lutterbach et al., 1998a; Amann et al., 2001; Hildebrand et al., 2001) . These interactions appear to be direct because coimmunoprecipitation experiments have revealed ETO fragments that can interact with HDACs independently of other corepressors (Amann et al., 2001) . Domains that disrupt interactions between ETO and HDAC complexes also disrupt ETO-mediated repression, consistent with HDACs being critical effectors of ETO (Gelmetti et al., 1998; Lutterbach et al., 1998b; Wang et al., 1998; Hildebrand et al., 2001) .
The finding that HDACs and corepressors from independent complexes can associate with ETO is intriguing. Several models potentially explain these interactions. First, ETO may serve as a platform upon which distinct complexes assemble. For example, NCoR and SMRT are capable of interacting with Sin3, and this interaction could be facilitated by ETO (Li et al., 1997; Nagy et al., 1997; Soderstrom et al., 1997) . Second, different complexes might associate with ETO in different cell types. Indeed, AML1-ETO corepressor recruitment domains have cell-type specific activities (Hug et al., 2002) . Third, ETO might recruit distinct HDAC complexes to different promoters. And fourth, HDACs could be recruited sequentially to influence ETO's activity. Technical advances such as the chromatin immunoprecipitation and RNA interference promise to reveal the mechanism by which ETO and HDACs participate in transcriptional regulation.
Indirect interactions with HDACs -nuclear receptor corepressor (N-CoR)/silencing mediator of retinoid and thyroid hormone receptor (SMRT)
The first interactions between ETO and corepressors were identified using yeast two-hybrid screens. N-CoR was cloned from a screen for leukemogenic proteins interacting with ETO . Independently, ETO was cloned in a screen for corepressors interacting with the N-CoR homologue SMRT (Gelmetti et al., 1998) . Together, these unbiased, reciprocal discoveries provide compelling evidence that the interaction between ETO and N-CoR or SMRT is nonrandom. The interactions have been validated by conventional GST-pulldown and immunoprecipitation assays (Gelmetti et al., 1998; Lutterbach et al., 1998b; Wang et al., 1998) . Most biochemical evidence supports a direct interaction between the NHR4 of ETO and repression domain 3 of N-CoR and SMRT (Gelmetti et al., 1998; Lutterbach et al., 1998a; Hildebrand et al., 2001; Zhang et al., 2001) . NHR2 of ETO enhances this interaction (Gelmetti et al., 1998; Lutterbach et al., 1998a; Hildebrand et al., 2001; Zhang et al., 2001) . Recently, an additional N-CoR contact site was identified between NHR1 and NHR2 of ETO (Amann et al., 2001) . Importantly, structure-function analyses have shown NHR2 and NHR4 to be important for the activity of AML1-ETO in cellular assays, suggesting a possible role for N-CoR or SMRT in repression by the oncoprotein (Gelmetti et al., 1998; Lutterbach et al., 1998b; Amann et al., 2001; Hildebrand et al., 2001; Hug et al., 2002) .
The N-CoR and SMRT complexes deacetylate localized histone targets designated by DNA-binding transcription factors (Li et al., 2002) . Biochemical purification of the complexes has shown that, in addition to N-CoR or SMRT, the complexes include HDAC3, Transducin Beta-Like and Transducin BetaLike Related (TBL1/TBLR1), GPS1, and IR10 (Guenther et al., 2000; Li et al., 2000; Zhang et al., 2002; Yoon et al., 2003) . HDAC3 is the putative enzymatic subunit of the complex and N-CoR or SMRT functions as an essential activating cofactor (Guenther et al., 2001) . Additionally, SMRT has been shown to bind deacetylated histone tails and may have a role in the maintenance of transcriptional repression (Yu et al., 2003) . TBL1 and TBLR1 contribute repression activity independently of N-CoR and SMRT (Guenther et al., 2000; Yoon et al., 2003) . They have the ability to bind histone H2B and H4 tails and are redundant components essential for the activity of the complex (Yoon et al., 2003) . Although N-CoR and SMRT have also been shown to associate nonstoichiometrically with components of other complexes such as SWI/SNF, KAP-1, and Sin3, chromatin immunoprecipitation analyses indicate that the complexes present at target promoters represent the classical N-CoR and SMRT complexes (Guenther et al., 2000; Li et al., 2000 Li et al., , 2002 Zhang et al., 2002; Ishizuka and Lazar, 2003; Yoon et al., 2003) . While ETO interacts with HDAC3, it is not known if it interacts with other components of the NCoR and SMRT complexes either directly or indirectly (Amann et al., 2001) .
Indirect interactions with HDACs-Sin3 complex
A candidate approach to identifying ETO-corepressor interactions revealed that ETO binds Sin3 (Lutterbach et al., 1998b) . Thus, corepressors outside of the N-CoR/ SMRT core complex potentially contribute activity to ETO. The NHR2 is important for the interaction between ETO and Sin3, but additional contacts are provided by sequences upstream and downstream of this region (Lutterbach et al., 1998b; Hildebrand et al., 2001) . Interestingly, ETO-2, the murine homologue of MTG16, does not interact with Sin3, and it is likely that non-conserved residues within and around NHR2 contribute to the differences between these family members (Amann et al., 2001) . Deletion of the Sin3 contact sites can compromise the activity of AML1-ETO consistent with this corepressor being important for ETO-mediated repression. However, as mentioned above, NHR2 also contributes to the recruitment of NCoR and SMRT, complicating the interpretation of the structure-function results (Lutterbach et al., 1998b; Amann et al., 2001; Hildebrand et al., 2001; Zhang et al., 2001; Hug et al., 2002) .
Sin3 appears to be involved in diverse cellular processes. While it can be directly recruited by selected transcription factors, such as MAD1, the Sin3 complex also appears to have a role in global genomic deacetylation (Li et al., 2002) . Purification of the Sin3 complex identified the cooperating components as HDAC1, HDAC2, Sin3-associated proteins 18 and 30 (SAP 18 and 30), and Rb-associated proteins 46 and 48 (RbAp46 and 48) (Zhang et al., 1997 (Zhang et al., , 1999 . The HDACs confer enzymatic potential on the complex and the other proteins are presumed to regulate or target this activity. For example, the RbAps likely present HDACs 1 and 2 to their chromatin substrate (Parthun et al., 1996; Zhang et al., 1998) . SAP18 and SAP30 appear to be important for interactions with selected transcriptional repressors and for HDAC activity in a subset of cellular HDAC1/2 complexes Espinas et al., 2000; Wang et al., 2002) . Consistent with the description of the N-CoR and SMRT complexes, Sin3 does not copurify with N-CoR or SMRT (Zhang et al., 1997 (Zhang et al., , 1999 . Additionally, while both HDAC1 and HDAC2 bind ETO, such interactions have not been demonstrated for the other members of the Sin3 complex (Amann et al., 2001 ).
Eto-Eto interactions
In addition to their abilities to recruit corepressors, ETO family members can interact with each other and form high molecular weight oligomers (Minucci et al., 2000; Zhang et al., 2001) . In fact, formation of complexes through homo-oligomerization appears essential for leukemogenic activity of fusion proteins such as AML1-ETO (Minucci et al., 2000; Zhang et al., 2001) . AML1-ETO can interact with itself as well as endogenous ETO and endogenous MTGR1 (Kitabayashi et al., 1998; Lutterbach et al., 1998a; Minucci et al., 2000; Zhang et al., 2001) . The oligomerization of ETO facilitates its interaction with N-CoR and SMRT (Zhang et al., 2001) . Deletion of the oligomerization domain impairs interaction with these corepressors; however, replacement of this domain with a heterologous oligomerization domain restores the interaction (Zhang et al., 2001) . Interestingly, the expression levels of different ETO family members have opposing effects on AML1-ETO activity. For example, overexpression of ETO inhibits AML1-ETO activity, whereas overexpression of MTGR1 enhances the activity (Kitabayashi et al., 1998; Lutterbach et al., 1998a) . This may be related to differences in corepressor recruitment by ETO family members, although this hypothesis has not formally been explored.
It is noteworthy that the NHR2 domain is important for the association of ETO with numerous factors. Sin3 is directly dependent on this domain and surrounding sequences for interactions with ETO (Lutterbach et al., 1998b; Amann et al., 2001; Hildebrand et al., 2001) . NCoR and SMRT are indirectly dependent on this domain to facilitate interactions with NHR4 (Hildebrand et al., 2001; Zhang et al., 2001) . Of course, NHR2-mediated oligomerization may itself be sufficient for the oncogenic activity of AML1-ETO (Minucci et al., 2000) . Since so many biochemical activities map to a single domain, it is currently difficult to conclude which activities are important for ETO and AML1-ETO function.
Conclusions
In the past 5 years, the mechanistic details underlying the leukemogenic properties of fusion protein transcription factors have been greatly elaborated. In particular, AML1-ETO appears to derive its oncogenic function from associations with one or more corepressor complexes. This underscores the importance of coregulator exchange in human disease. Nevertheless, the field is still in its infancy. It appears that ETO is capable of interactions with numerous transcriptional corepressors including multiple HDACs and components of numerous core complexes. As the specific functions of the complexes themselves are still vague outside of a capacity to deacetylate histones, it is not yet possible to draw conclusions about the scope or breadth of effects ETO may have on gene expression. It is likely that advances in the understanding of transcriptional biology will lead to greater insight into the mechanisms of disregulation of gene expression by AML1-ETO.
